Albemarle Corporation ALB
Nov 10, 2026, 10:17 AM EST
- YTD
- -32.42%
- 1 year
- -7.72%
- Market cap
- 11.27B
- Revenue (ttm)
- 6.15B
- Profit margin
- 11.08%
- EPS (ttm)
- 4.15
- Shares out
- 118.01M
- P/E ratio
- 23.01
- Forward P/E
- 10.74
- Dividend
- 1.64 (1.81%)
- Ex-dividend date
- Dec 17, 2026
- YTD return
- -32.42%
- 1-year return
- -7.72%
- Volume
- 233.45K
- Avg volume
- 2.43M
- Open
- 96.65
- Previous close
- 99.12
- Day's range
- 94.46 – 97.18
- 52-week range
- 90.19 – 215.62
- Beta
- 1.36
- Analysts
- Buy
- Price target
- 142.35 (+48.9%)
- Earnings date
- Feb 10, 2027
5D +2.11 (+2.25%)
Key statistics
- Enterprise value
- 14.38B
- PEG ratio
- 0.79
- Price / sales
- 1.90
- Price / book
- 1.41
- Dividend yield
- 1.65%
- Payout ratio
- 39.16%
- Revenue growth
- 18.80%
- Free cash flow
- 1.25B
- Total cash
- 1.85B
- Total debt
- 2.00B
- Return on equity
- 7.05%
- Short % of float
- 0.06%
- 50-day average
- 107.55
- 200-day average
- 147.96
Analyst view
Consensus: buy
- Target (low)
- 83.28
- Target (mean)
- 142.35
- Target (high)
- 211.00
- Strong buy3
- Buy11
- Hold9
- Sell0
- Strong sell0
Next earnings
Feb 10, 2027
Expected Feb 10, 2027. Consensus EPS estimate 1.41.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2027 | Dec 30, 2026 | 1.94 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 2.53 | 2.58 | +0.05 | +1.98% |
| Aug 5, 2026 | Jun 30, 2026 | 3.20 | 3.75 | +0.55 | +17.19% |
| May 6, 2026 | Mar 31, 2026 | 1.19 | 2.95 | +1.76 | +147.90% |
| Feb 11, 2026 | Dec 31, 2025 | -0.41782 | -0.53 | -0.11 | -26.85% |
| Nov 5, 2025 | Sep 30, 2025 | -0.86146 | -0.19 | +0.67 | +77.94% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | Citigroup | main | Buy | Buy |
| Nov 9, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Nov 9, 2026 | Scotiabank | main | Sector Outperform | Sector Outperform |
| Nov 6, 2026 | Truist Securities | reit | Buy | Buy |
| Nov 6, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 6, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
About Albemarle Corporation
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- albemarle.com
News
UBS Maintains Buy on Albemarle, Lowers Price Target to $137 
Citigroup Maintains Buy on Albemarle, Raises Price Target to $140 - Morgan Stanley Maintains Equal-Weight on Albemarle, Lowers Price Target to $105
Scotiabank Maintains Sector Outperform on Albemarle, Lowers Price Target to $165 - Truist Securities Reiterates Buy on Albemarle, Lowers Price Target to $170
RBC Capital Maintains Outperform on Albemarle, Lowers Price Target to $119 - Barclays Maintains Equal-Weight on Albemarle, Lowers Price Target to $95
What Albemarle (ALB) Said on Its Q3 Earnings Call 
Albemarle Corporation (ALB) Q3 2026 Earnings Call Transcript 
Albemarle Q3 2026 Earnings Call Transcript
Your note
Sign in to keep a note on ALB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDERSON MELISSA HANFT | Officer | Stock Award(Grant) | Mar 1, 2026 | 14,181 |
| BRLAS MARY LAURIE | Director | Stock Award(Grant) | Jun 30, 2026 | 14,189 |
| JOHNSON NETHA N | Chief Operating Officer | Conversion of Exercise of derivative security | Feb 26, 2025 | 42,114 |
| LABAUVE DONALD J JR | Officer | Stock Award(Grant) | Mar 1, 2026 | 23,157 |
| LIMA CYNTHIA RENEE | Officer | Stock Award(Grant) | Mar 1, 2026 | 14,438 |
| MASTERS JERRY KENT JR. | Chief Executive Officer | Sale | May 14, 2026 | 87,519 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Capital World Investors | 8.39% | 9,901,852 | 981.27M | Jun 29, 2026 |
| Blackrock Inc. | 8.05% | 9,501,587 | 941.61M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 7,703,012 | 763.37M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.45% | 6,436,930 | 637.90M | Jun 29, 2026 |
| State Street Corporation | 4.66% | 5,500,062 | 545.06M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.66% | 3,141,782 | 311.35M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AMERICAN BALANCED FUND | 3.39% | 4,000,000 | 396.40M | Sep 29, 2026 |
| Growth Fund of America | 3.38% | 3,993,326 | 395.74M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,744,367 | 371.07M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 3,054,213 | 302.67M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 2,704,000 | 267.97M | Jun 29, 2026 |
| ProShares Trust-ProShares S&P 500 Dividend Aristocrats ETF | 1.50% | 1,773,908 | 175.79M | Oct 30, 2026 |